Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 718 | 657 | 678 | 692 | 572 |
| Cost of Goods | 403 | N/A | 333 | 371 | 302 |
| Gross Profit | 315 | 331 | 345 | 321 | 270 |
| Operating Expenses | 1,513 | 866 | 1,361 | 874 | 1,121 |
| Operating Income | -1,198 | -536 | -1,016 | -554 | -852 |
| Interest Expense | 277 | N/A | 240 | 288 | 238 |
| Other Income | 30 | 536 | 11 | 3 | 50 |
| Pre-tax Income | -1,446 | N/A | -1,245 | -838 | -1,039 |
| Net Income Continuous | -1,446 | -968 | -1,245 | -838 | -1,039 |
| Minority Interests | 67 | N/A | 44 | -32 | 28 |
| Net Income | $-1,378 | $-873 | $-1,201 | $-870 | $-1,011 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EBITDA(a) | $-1,104 | $-476 | $-942 | $-485 | $-737 |